FR2278325B1 - - Google Patents

Info

Publication number
FR2278325B1
FR2278325B1 FR7425203A FR7425203A FR2278325B1 FR 2278325 B1 FR2278325 B1 FR 2278325B1 FR 7425203 A FR7425203 A FR 7425203A FR 7425203 A FR7425203 A FR 7425203A FR 2278325 B1 FR2278325 B1 FR 2278325B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7425203A
Other languages
French (fr)
Other versions
FR2278325A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to FR7425203A priority Critical patent/FR2278325A1/fr
Publication of FR2278325A1 publication Critical patent/FR2278325A1/fr
Application granted granted Critical
Publication of FR2278325B1 publication Critical patent/FR2278325B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7425203A 1974-07-19 1974-07-19 Complexe renfermant un antibiotique Granted FR2278325A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7425203A FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7425203A FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Publications (2)

Publication Number Publication Date
FR2278325A1 FR2278325A1 (fr) 1976-02-13
FR2278325B1 true FR2278325B1 (US07122547-20061017-C00273.png) 1978-07-28

Family

ID=9141501

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7425203A Granted FR2278325A1 (fr) 1974-07-19 1974-07-19 Complexe renfermant un antibiotique

Country Status (1)

Country Link
FR (1) FR2278325A1 (US07122547-20061017-C00273.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723846B1 (fr) * 1994-08-24 1997-06-13 Hi Pharmtech Forme pharmaceutique solide pour l'administration d'une substance active liquide liposoluble

Also Published As

Publication number Publication date
FR2278325A1 (fr) 1976-02-13

Similar Documents

Publication Publication Date Title
FR2283584B1 (US07122547-20061017-C00273.png)
FR2278325B1 (US07122547-20061017-C00273.png)
JPS50100291U (US07122547-20061017-C00273.png)
JPS50100167U (US07122547-20061017-C00273.png)
FR2296830B2 (US07122547-20061017-C00273.png)
FR2277246B1 (US07122547-20061017-C00273.png)
CS173334B1 (US07122547-20061017-C00273.png)
JPS50103316A (US07122547-20061017-C00273.png)
HU168228B (US07122547-20061017-C00273.png)
FR2272992A1 (US07122547-20061017-C00273.png)
FR2259506A1 (US07122547-20061017-C00273.png)
CS161595B1 (US07122547-20061017-C00273.png)
BG22484A1 (US07122547-20061017-C00273.png)
BG21285A1 (US07122547-20061017-C00273.png)
DD111026A5 (US07122547-20061017-C00273.png)
DD124387A5 (US07122547-20061017-C00273.png)
AU482110A (US07122547-20061017-C00273.png)
CH609174A5 (US07122547-20061017-C00273.png)
CH580873A5 (US07122547-20061017-C00273.png)
CH1357474A4 (US07122547-20061017-C00273.png)
CH1107074A4 (US07122547-20061017-C00273.png)
BG26152A1 (US07122547-20061017-C00273.png)
BG23188A1 (US07122547-20061017-C00273.png)
BG22732A1 (US07122547-20061017-C00273.png)
BG21632A1 (US07122547-20061017-C00273.png)

Legal Events

Date Code Title Description
ST Notification of lapse